Daejeon, South Korea

Sang Hun Jung

USPTO Granted Patents = 2 

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Sang Hun Jung

Introduction

Sang Hun Jung is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His work has led to the filing of multiple patents, showcasing his innovative approach to cancer treatment.

Latest Patents

Sang Hun Jung holds two patents related to arylsulfonylimidazolone derivatives as antitumor agents. These novel compounds demonstrate superior antineoplastic activity compared to existing sulfonylurea antitumor agents, while also exhibiting minimal side effects. The patents detail the chemical structures and formulations of these derivatives, emphasizing their potential in cancer therapy.

Career Highlights

Sang Hun Jung is currently employed at Dongwha Pharm. Ind. Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work at the company has positioned him as a key player in the development of new therapeutic agents.

Collaborations

He collaborates with esteemed colleagues, including Sung June Yoon and Yong Ho Chung, who contribute to his research efforts and enhance the innovative environment at Dongwha Pharm.

Conclusion

Sang Hun Jung's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his commitment to advancing cancer treatment. His work exemplifies the impact of dedicated inventors in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…